Download PDF
Exp Clin Endocrinol Diabetes 2021; 129(03): 250-264
DOI: 10.1055/a-1373-4087
Guideline

First German Guideline on Diagnostics and Therapy of Clinically Non-Functioning Pituitary Tumors

Timo Deutschbein 
1   Department of Internal Medicine I, Division of Endocrinology and Diabetes, University Hospital Würzburg, University of Würzburg, Würzburg, Germany
2   Medicover Oldenburg MVZ, Oldenburg, Germany
,
Cornelia Jaursch-Hancke
3   Department of Endocrinology, German Clinic of Diagnostics, Wiesbaden, Germany
,
Ulrich J. Knappe
4   Department of Neurosurgery, Johannes Wesling Hospital, University Hospital of the Ruhr-University Bochum, Minden, Germany
,
Wolfgang Saeger
5   Institute for Neuropathology, University Hospital Hamburg-Eppendorf, Hamburg, Germany
,
Jörg Flitsch
6   Department of Neurosurgery, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
,
Jörg Bojunga
7   Department of Internal Medicine I, Division of Endocrinology, Goethe-University Hospital, Frankfurt, Germany
,
Michael Buchfelder
8   Department of Neurosurgery, University Hospital Erlangen, Friedrich-Alexander University of Erlangen-Nürnberg, Erlangen, Germany
,
Beate Ditzen
9   Institute of Medical Psychology, Center for Psychosocial Medicine, University Hospital Heidelberg, Ruprecht-Karls University Heidelberg, Heidelberg, Germany
,
Rüdiger Gerlach
10   Department of Neurosurgery, Helios Klinikum Erfurt, Erfurt, Germany
,
Elfriede Gertzen
11   Niels Stensen Bildungszentrum, Osnabrück, Germany
,
Jürgen Honegger
12   Department of Neurosurgery, University Hospital Tübingen, Eberhard-Karls-University Tübingen, Germany
,
Gerhard A. Horstmann
13   Gamma Knife Center Krefeld, Krefeld, Germany
,
Arend Koch
14   Department of Neuropathology, Berlin Institute of Health, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität Zu Berlin, Berlin, Germany
,
Ilonka Kreitschmann-Andermahr 
15   Department of Neurosurgery and Spine Surgery, University Medicine Essen, University of Duisburg-Essen, Essen, Germany
,
Mirjam Kunz
16   Schwerpunktpraxis für Diabetologie und Endokrinologie, Ludwigshafen, Germany
,
Wolf A. Lagrèze
17   Eye Center, Medical Center, Medical Faculty, University of Freiburg, Germany
,
Nils H. Nicolay
18   Department of Radiation Oncology, University of Freiburg – Medical Center, Freiburg, Germany
,
Werner Paulus
19   Institute of Neuropathology, University Hospital Münster, Münster, Germany
,
Martin Reincke
20   Medizinische Klinik und Poliklinik IV, Klinikum der Universität, Ludwig-Maximilians-Universität München, München, Germany
,
Manuel A. Schmidt
21   Department of Neuroradiology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany
,
Matthias M. Weber
22   Department of Endocrinology and Metabolism, I Medical Clinic, University Hospital, Johannes Gutenberg University of Mainz, Mainz, Germany
,
Helmut Wilhelm
23   Centre for Ophthalmology, University Hospital Tübingen, Eberhard-Karls-University Tübingen, Tübingen, Germany
,
Martin Fassnacht
1   Department of Internal Medicine I, Division of Endocrinology and Diabetes, University Hospital Würzburg, University of Würzburg, Würzburg, Germany
› Author Affiliations Funding: The guideline was initiated by the German Society of Endocrinology. All incurring costs were financed exclusively by the German Society of Endocrinology and the participating professional societies.
› Further Information
Also available at
   Permissions and Reprints

Abstract

Although non-functioning pituitary tumors are frequent, diagnostic and therapeutic concepts are not well standardized. We here present the first German multidisciplinary guideline on this topic. The single most important message is to manage the patients by a multidisciplinary team (consisting at least of an endocrinologist, a neurosurgeon, and a (neuro-) radiologist). The initial diagnostic work-up comprises a detailed characterization of both biochemical (focusing on hormonal excess or deficiency states) and morphological aspects (with magnetic resonance imaging of the sellar region). An ophthalmological examination is only needed in presence of symptoms or large tumors affecting the visual system. Asymptomatic, hormonally inactive tumors allow for a 'wait and scan' strategy. In contrast, surgical treatment by an experienced pituitary surgeon is standard of care in case of (impending) visual impairment. Therapeutic options for incompletely resected or recurrent tumors include re-operation, radiotherapy, and observation; the individual treatment plan should be developed multidisciplinary. Irrespective of the therapeutic approach applied, patients require long-term follow-up. Patient with larger pituitary tumors or former surgery/radiotherapy should be regularly counseled regarding potential symptoms of hormonal deficiency states.

Key words

Adenoma - endocrinology - hormonally inactive - hormones - imaging - neuropathology - neuroradiology - neurosurgery - NFA - pathology - radiology - radiotherapy - recommendation - surgery - sellar mass - treatment.

Supplementary material



Publication History

Received: 23 January 2021
Received: 23 January 2021

Accepted: 25 January 2021

Article published online:
09 March 2021

© 2021. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References

  • 1 Alexander EK, Pearce EN, Brent GA. et al. Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum. 2017; Thyroid 27: 315-389
    CrossrefPubMedGoogle Scholar
  • 2 American College of O, Gynecologists' Committee on Obstetric P Committee OpinionSummary: Guidelines for Diagnostic Imaging During Pregnancy and Lactation. Obstet Gynecol 2016; 127: 418
    CrossrefPubMedGoogle Scholar
  • 3 Casanueva FF, Molitch ME, Schlechte JA. et al. Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas. Clin Endocrinol (Oxf) 2006; 65: 265-273
    CrossrefPubMedGoogle Scholar
  • 4 De Groot L, Abalovich M, Alexander EK. et al. Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2012; 97: 2543-2565
    CrossrefPubMedGoogle Scholar
  • 5 Fleseriu M, Bodach ME, Tumialan LM. et al. Congress of neurological surgeons systematic review and evidence-based guideline for pretreatment endocrine evaluation of patients with nonfunctioning pituitary adenomas. Neurosurgery 2016; 79: E527-E529
    CrossrefPubMedGoogle Scholar
  • 6 Freda PU, Beckers AM, Katznelson L. et al. Pituitary incidentaloma: An endocrine society clinical practice guideline. J Clin Endocrinol Metab 2011; 96: 894-904
    CrossrefPubMedGoogle Scholar
  • 7 Inder WJ, Hunt PJ. Glucocorticoid replacement in pituitary surgery: Guidelines for perioperative assessment and management. J Clin Endocrinol Metab 2002; 87: 2745-2750
    CrossrefPubMedGoogle Scholar
  • 8 Katznelson L, Laws ER, Melmed S. et al. Acromegaly: An endocrine society clinical practice guideline. J Clin Endocrinol Metab 2014; 99: 3933-3951
    CrossrefPubMedGoogle Scholar
  • 9 Kuo JS, Barkhoudarian G, Farrell CJ. et al. Congress of neurological surgeons systematic review and evidence-based guideline on surgical techniques and technologies for the management of patients with nonfunctioning pituitary adenomas. Neurosurgery 2016; 79: E536-E538
    CrossrefPubMedGoogle Scholar
  • 10 Lucas JW, Bodach ME, Tumialan LM. et al. Congress of neurological surgeons systematic review and evidence-based guideline on primary management of patients with nonfunctioning pituitary adenomas. Neurosurgery 2016; 79: E533-E535
    CrossrefPubMedGoogle Scholar
  • 11 Melmed S, Casanueva FF, Hoffman AR. et al. Diagnosis and treatment of hyperprolactinemia: An Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011; 96: 273-288
    CrossrefPubMedGoogle Scholar
  • 12 Nieman LK, Biller BM, Findling JW. et al. The diagnosis of Cushing's syndrome: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2008; 93: 1526-1540
    CrossrefPubMedGoogle Scholar
  • 13 Raverot G, Burman P, McCormack A. et al. European Society of Endocrinology Clinical Practice Guidelines for the management of aggressive pituitary tumours and carcinomas. Eur J Endocrinol 2018; 178: G1-G24
    CrossrefPubMedGoogle Scholar
  • 14 Nomikos P, Ladar C, Fahlbusch R. et al. Impact of primary surgery on pituitary function in patients with non-functioning pituitary adenomas -- a study on 721 patients. Acta Neurochir (Wien) 2004; 146: 27-35
    CrossrefPubMedGoogle Scholar
  • 15 Raverot G, Assie G, Cotton F. et al. 2015; Biological and radiological exploration and management of non-functioning pituitary adenoma. Ann Endocrinol (Paris) 76: 201-209
    CrossrefPubMedGoogle Scholar
  • 16 Chanson P, Raverot G, Castinetti F. et al. French Endocrinology Society non-functioning pituitary adenoma w-g 2015 Management of clinically non-functioning pituitary adenoma. Ann Endocrinol (Paris) 76: 239-247
    PubMedGoogle Scholar
  • 17 Puataweepong P, Dhanachai M, Hansasuta A. et al. Clinical outcomes of perioptic tumors treated with hypofractionated stereotactic radiotherapy using CyberKnife(R) stereotactic radiosurgery. J Neurooncol 2018; 139: 679-688
    CrossrefPubMedGoogle Scholar
  • 18 Louis DN, Perry A, Reifenberger G. et al. The 2016 World Health Organization Classification of Tumors of the Central Nervous System: A summary. Acta Neuropathol 2016; 131: 803-820
    CrossrefPubMedGoogle Scholar
  • 19 Osamura R, Lopes MBS, Grossman A. et al. Tumours of the pituitary gland. In Lloyd RV, Osamura RY, Klöppel G, Rosai J. WHO Classification of Tumours of Endocrine Organs. 4 ed.. Heidelberg-Berlin: Springer; 2017
    Google Scholar
  • 20 Ronchi CL, Peverelli E, Herterich S. et al. Landscape of somatic mutations in sporadic GH-secreting pituitary adenomas. Eur J Endocrinol 2016; 174: 363-372
    CrossrefPubMedGoogle Scholar
  • 21 Sbiera S, Perez-Rivas LG, Taranets L. et al. Driver mutations in USP8 wild type Cushing's disease. Neuro Oncol. 2019;
    PubMed
  • 22 Iacovazzo D, Hernandez-Ramirez LC, Korbonits M. Sporadic pituitary adenomas: the role of germline mutations and recommendations for genetic screening. Expert Rev Endocrinol Metab 2017; 12: 143-153
    CrossrefPubMedGoogle Scholar
  • 23 Knappe UJ, Moskopp D, Gerlach R. et al. Consensus on Postoperative Recommendations After Transsphenoidal Surgery. Exp Clin Endocrinol Diabetes 2019; 127: 29-36
    PubMedGoogle Scholar
  • 24 Arita K, Tominaga A, Sugiyama K. et al. Natural course of incidentally found nonfunctioning pituitary adenoma, with special reference to pituitary apoplexy during follow-up examination. J Neurosurg 2006; 104: 884-891
    CrossrefPubMedGoogle Scholar
  • 25 Irvine WJ, Barnes EW. Adrenocortical insufficiency. Clinics in Endocrinology and Metabolism 1972; 1: 549-594
    CrossrefPubMedGoogle Scholar
  • 26 Knowlton AI, Baer L. Cardiac failure in Addison's disease. Am J Med 1983; 74: 829-836
    CrossrefPubMedGoogle Scholar
  • 27 Lindsay JR, Nieman LK. The hypothalamic-pituitary-adrenal axis in pregnancy: Challenges in disease detection and treatment. Endocr Rev 2005; 26: 775-799
    CrossrefPubMedGoogle Scholar
  • 28 Saklad M. Grading of patients for surgical procedures. Anesthesiology 1941; 2: 281-284
    CrossrefPubMedGoogle Scholar
  • 29 Gerlach R, Krause M, Seifert V. et al. Hemostatic and hemorrhagic problems in neurosurgical patients. Acta Neurochir (Wien) 2009; 151: 873-900 Discussion 900
    CrossrefPubMedGoogle Scholar